Expression Analysis and Genotyping of DGKZ: a GWAS-derived Risk Gene for Schizophrenia
Overview
Authors
Affiliations
Schizophrenia (SCZ) is a disabling and severe mental illness characterized by abnormal social behavior and disrupted emotions. Similar to other neuropsychological disorders, both genetics and environmental factors interplay so as to develop SCZ. It is acknowledged that genes such as DGKZ are involved in lipid signaling pathways that are the basis of neural activities, memory, and learning and are considered as candidate loci for SCZ. The aim of the present study was to evaluate the expression level and genotypes of DGKZ in patients with SCZ and controls. We used q-PCR to measure the relative expression of DGKZ in blood. To determine DGKZ-rs7951870 genotypes, tetra-ARMS PCR was used. Our results showed a significant difference in DGKZ mRNA ratio between SCZ patients and healthy controls (P = 2 × 10). Also, we showed that rs7951870-TT genotype was strongly associated with increased DGKZ expression level (P = 0.038). In conclusion, our findings revealed dysregulation of DGKZ in SCZ patients and a significant correction between the gene expression and DGKZ variant rs7951870.
Modesti M, Arena J, Del Casale A, Gentile G, Borro M, Parmigiani G Lipids Health Dis. 2025; 24(1):89.
PMID: 40069786 PMC: 11895309. DOI: 10.1186/s12944-025-02512-x.
Whole-genome sequencing identifies novel genes for autism in Chinese trios.
Chang S, Liu J, Zhao Y, Pang T, Zheng X, Song Z Sci China Life Sci. 2024; 67(11):2368-2381.
PMID: 39126614 DOI: 10.1007/s11427-023-2564-8.
Genetic control of RNA splicing and its distinct role in complex trait variation.
Qi T, Wu Y, Fang H, Zhang F, Liu S, Zeng J Nat Genet. 2022; 54(9):1355-1363.
PMID: 35982161 PMC: 9470536. DOI: 10.1038/s41588-022-01154-4.
Non-coding de novo mutations in chromatin interactions are implicated in autism spectrum disorder.
Kim I, Lee T, Lee J, Kim J, Lee S, Koh I Mol Psychiatry. 2022; 27(11):4680-4694.
PMID: 35840799 DOI: 10.1038/s41380-022-01697-2.
Finding associations in a heterogeneous setting: statistical test for aberration enrichment.
Mezlini A, Das S, Goldenberg A Genome Med. 2021; 13(1):68.
PMID: 33892787 PMC: 8066476. DOI: 10.1186/s13073-021-00864-4.